Skip to main content
. Author manuscript; available in PMC: 2013 Jul 2.
Published in final edited form as: Auton Neurosci. 2012 Apr 28;169(1):56–61. doi: 10.1016/j.autneu.2012.04.001

Table 3.

Multivariable assessment of associations between neuropathy measures.

Parameter Regression coefficient (95% CI)a p
Total sweat volume by QSART and total UENS score
 Variable
  UENS score 0.79 (0.68–0.92) 0.003
  Age (unit=1 year) 0.98 (0.86–1.12) 0.81
  CD4+ T cells (unit = 100 cells/mm3) 1.00 (0.99–1.00) 0.08
  Sex 0.61 (0.06–5.96) 0.66
  Current or prior d-drug NRTI use 0.33 (0.03–3.72) 0.36
Total sweat volume by QSART and worst pain over past week by VAS
 Variable
  Worst pain over past week 0.96 (0.91–1.02) 0.20
  Age (unit=1 year) 0.98 (0.84–1.13) 0.79
  CD4+ T cells (unit = 100 cells/mm3) 1.00 (0.99–1.00) 0.08
  Sex 0.84 (0.05–12.89) 0.90
  Current or prior d-drug NRTI use 0.34 (0.02–5.18) 0.42
Total UENS score and worst pain over past week by VAS
 Variable
  Worst pain over last week 1.25 (1.17–1.34) <0.001
  Age (unit=1 year) 1.03 (0.87–1.23) 0.66
  CD4+ T cells (unit = 100 cells/mm3) 0.99 (0.99–1.00) 0.62
  Sex 0.10 (0.00–2.46) 0.15
  Current or prior d-drug NRTI use 0.46 (0.01–11.07) 0.62
a

Data are exponential of regression coefficients (95% confidence interval), which indicates fold change in the outcome variable of interest by one interquartile increase in the corresponding covariate.

CI=confidence interval, QSART=quantitative sudomotor axon reflex test, UENS=Utah Early Neuropathy Scale, VAS=visual analog scale, NRTI=nucleoside reverse transcriptase inhibitor